Replies to post #2246 on Acadia Pharmaceuticals Inc. (ACAD)

[porgyrusty]

No way they take $42 per share. Originally they said they wouldn't sell for anything under $60, and if the Alzheimers results come back positive then all bets are off.

[Rymankoly]

Looks like they corrected the $23 to $24 at the time of the twitt (look at today chart).
$42 is more realistic but don't take into account the possibility of success with the Alzheimer indication.